Depression during pregnancy affects an estimated 10–15% of pregnant women. It is not something to hide, minimise, or “wait out.” Untreated antenatal depression is associated with real risks — for the mother’s health, for pregnancy complications, and for infant outcomes. But treating depression during pregnancy involves a complicated balancing act. Medications carry potential risks to the developing foetus. Psychotherapy alone may not be enough for moderate to severe depression. TMS in pregnancy has emerged as one of the few evidence-supported non-medication options.
This guide explains TMS safety during pregnancy, when it may be considered, and how it fits into prenatal depression treatment.
At Mind Brain Institute, we prescribe medication when it’s clinically indicated and consider TMS as an option after full psychiatric and obstetric review. Every treatment decision in pregnancy is individualised.
Is TMS safe during pregnancy?
Current evidence suggests TMS is generally safe during pregnancy when properly delivered. Because the magnetic field falls off rapidly with distance, the electromagnetic effect at the level of the abdomen is negligible — there is no direct stimulation of foetal tissue.
Published case series and small studies of TMS during pregnancy have not shown significant adverse effects on the developing foetus or pregnancy outcomes. Reported side effects for the mother are the same as in non-pregnant patients: mild scalp discomfort, occasional headache.
That said, evidence is still limited compared to more established treatments. TMS during pregnancy remains an individualised clinical decision made with the treating psychiatrist and obstetrician.
Can TMS therapy be used to treat depression during pregnancy?
Yes, in appropriately selected patients. TMS therapy in Delhi may be considered when:
- Depression is moderate to severe and impacting the mother’s functioning
- Antidepressant medication carries concerns (either due to specific pregnancy-related risks, prior tolerability issues, or patient preference)
- Psychotherapy alone hasn’t produced adequate response
- The patient and obstetric team are involved in a coordinated treatment plan
At MBI, depression treatment during pregnancy is always coordinated with the patient’s obstetrician.
Is TMS safer than antidepressants during pregnancy?
The answer is nuanced and depends on the medication in question.
Some antidepressants have accumulated substantial safety data in pregnancy and are considered relatively low-risk. Others have specific concerns. For any medication, the risk-benefit calculation must weigh maternal untreated depression (which itself carries risks) against potential medication-related risks.
TMS, being non-systemic, does not expose the foetus to any medication. For patients who cannot or prefer not to take antidepressants during pregnancy, this is a meaningful advantage.
However, the trade-off is that TMS requires daily clinic visits for 4–6 weeks — logistically harder for many pregnant patients than taking a daily pill.
How does TMS treatment work for pregnant women with depression?
Practical considerations for pregnant patients:
- Positioning: patients are seated in a comfortable chair; special care is taken with positioning to accommodate pregnancy
- No medication or sedation is administered
- Each session lasts 20–40 minutes
- The magnetic coil is applied only to the scalp; the abdomen and pelvis are entirely outside the effective field
- Standard 20–30 session course over 4–6 weeks
Some patients respond to accelerated protocols (SAINT, One-Day TMS), which can compress treatment for those who cannot commit to daily sessions over weeks. Eligibility is determined individually.
Are there any risks or side effects of TMS during pregnancy?
For the mother, the standard TMS side effects apply: mild scalp discomfort during the session, occasional transient headache in the first week. Very rare seizure risk exists as in non-pregnant patients (<1 in 30,000 sessions).
For the pregnancy, published evidence has not identified specific TMS-related risks. But because overall data is still limited, ongoing safety monitoring is part of best practice.
Patients with:
- History of seizures
- Ferromagnetic implants near the head
- Certain pregnancy complications
may not be appropriate candidates and should discuss alternatives with their treating team.
The decision-making process
Before starting TMS during pregnancy, expect:
- Full psychiatric assessment (severity, prior treatments, current symptoms)
- Obstetric review and coordination
- Discussion of alternatives (medication options, psychotherapy, expectant management)
- Clear informed consent covering what is and isn’t known
- Ongoing communication between psychiatry and obstetrics throughout treatment
Untreated depression during pregnancy is not a safe alternative — it carries its own risks for both mother and baby. The right treatment depends on your specific situation.
FAQ
Is TMS safe during pregnancy?
Current evidence suggests TMS is generally safe during pregnancy when properly delivered. Evidence is still limited compared to more established treatments. Treatment decisions are individualised.
Can TMS therapy be used to treat depression during pregnancy?
Yes, in appropriately selected patients — particularly when medication concerns or intolerance are factors. Requires coordinated psychiatric and obstetric care.
Is TMS safer than antidepressants during pregnancy?
Depends on the specific medication. TMS is non-systemic (no foetal medication exposure), but antidepressants have longer safety records. Both options carry risks and benefits to weigh with your treatment team.
How does TMS treatment work for pregnant women with depression?
Same procedure as non-pregnant patients — 20–30 sessions over 4–6 weeks. The magnetic field is localised to the scalp; the abdomen is not affected.
Are there any risks or side effects of TMS during pregnancy?
Standard TMS side effects (scalp discomfort, occasional headache). No pregnancy-specific risks have been established in published studies, though overall data remains limited.
